Worldwide, diabetes is a rapidly growing problem that is managed at the individual level by monitoring and controlling blood glucose levels to minimize the negative effects of the disease. Because of limitations in diagnostic methods, significant research efforts are focused on developing improved methods to measure glucose. Nanotechnology has impacted these efforts by increasing the surface area of sensors, improving the catalytic properties of electrodes and providing nanoscale sensors. Herein, we discuss developments in the past several years on both nanosensors that directly measure glucose as well as nanomaterials that improve glucose sensor function. Finally, we discuss challenges that must be overcome to apply these developments in the clinic.
KeywordsBiosensor; Glucose Oxidase; Direct Oxidation; Quantum Dot; Nanoparticle; Nanosensor; Carbon nanotube; Smart tattoo; Continuous monitoring
Diabetes and Blood Glucose MonitoringDiabetes is a rapidly growing problem, currently affecting 24 million people in the US alone [1]. This number could increase to 44.1 million by 2034 with treatment costs approaching $336 billion (in 2007 dollars) [2]. Diabetes can lead to complications such as serious as lower-limb amputations, blindness, and cardiovascular disease [1]. Although there is no cure for diabetes, patients can reduce disease-associated complications through the tight control of blood glucose levels [1].In order to attain optimal control, patients must monitor their blood glucose levels. Currently, this requires a patient to obtain a small sample of blood, usually via a finger prick. Blood is placed onto a sensor test strip that is then read by a handheld electronic reader, which reports the blood glucose concentration. These sensors are based on electrochemical enzymatic measurements ( Figure 1) with screen printed electrodes [3] and provide rapid and accurate measurements of blood glucose without the need for laboratory analysis. However, there are limitations to this approach including painful sampling, analyses cannot be performed if the patient is otherwise occupied (e.g. sleeping) and large fluctuations between sampling time points are missed [4,5]. To help overcome the problems * Corresponding author: h.clark@neu.edu.Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Box 1
Continuous glucose monitoringTraditional monitoring of blood glucose uses discrete blood sampling time points during the course of a day. For many diabetics this provides satisfactory data for the control of blood glucose levels. However, inherent in this approach lays ...